| Name | Title | Contact Details |
|---|---|---|
Adam Koering |
Chief Financial Officer | Profile |
Nathan Meadows |
Regional Sales Director | Profile |
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
Sunlit Gardens Assisted Living is a Rancho Cucamonga, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Se2 Spielman Engineering is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RealAge, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Eye Surgeon Associates is a Bettendorf, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.